O079 Investigating Hypersomnolence Disorders in South Australia: A Retrospective Audit of Multiple Sleep Latency tests

M O'Reilly, S Mukherjee, C Chai Coetzer, J Mercer, S Ullah, G Naik, P Catcheside, A Walker
{"title":"O079 Investigating Hypersomnolence Disorders in South Australia: A Retrospective Audit of Multiple Sleep Latency tests","authors":"M O'Reilly, S Mukherjee, C Chai Coetzer, J Mercer, S Ullah, G Naik, P Catcheside, A Walker","doi":"10.1093/sleepadvances/zpad035.079","DOIUrl":null,"url":null,"abstract":"Abstract Introduction This study aims to evaluate the characteristics of patients with Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), and Idiopathic Hypersomnolence (IH) along with diagnostic outcomes in patients referred for a multiple sleep latency test (MSLT) at an Australian hospital. Methods A retrospective audit was performed of all patients who completed an MSLT between January 2018 to January 2023. Results 431 participants (62.4% female; mean±SD age 40.2±16.4 years; BMI 28.6±7.4 kg/m²) who completed MSLTs were included. 95 participants (22%) had a positive MSLT of ≤ 8 minutes, of which 87% (n=83) had a prior night total sleep time on polysomnography of > 6 hours. Gender, age, and BMI did not vary significantly between participants with a mean sleep latency (MSL) ≤ 8 versus >8 minutes (p=0.9, p>0.9, p=0.1 0, respectively). Participants with an MSL ≤ 8 minutes had higher Epworth Sleepiness Scale scores 14.6 ± 5.1 vs 12.5 ± 5.0 (p < 0.001), with more sleep onset REM periods (SOMREPs) 0.82 ± 1.35 vs 0.14 ± 0.49 compared to those with MSL >8 minutes. Further data collection is in progress, but to date, diagnoses were available for 34 participants with MSL ≤ 8 minutes (6 NT1, 8 NT2, 8 IH, 12 Other [i.e., shiftwork disorder, sleep restriction, medication-induced]). Discussion This study seeks to estimate diagnostic frequency and characteristics of patients presenting for evaluation of hypersomnolence. The prevalence of MSL < 8 minutes (22.0%) is consistent with prior studies1,2. Analysis of diagnostic outcomes is pending further data collection in progress.","PeriodicalId":21861,"journal":{"name":"SLEEP Advances","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"SLEEP Advances","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/sleepadvances/zpad035.079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Introduction This study aims to evaluate the characteristics of patients with Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), and Idiopathic Hypersomnolence (IH) along with diagnostic outcomes in patients referred for a multiple sleep latency test (MSLT) at an Australian hospital. Methods A retrospective audit was performed of all patients who completed an MSLT between January 2018 to January 2023. Results 431 participants (62.4% female; mean±SD age 40.2±16.4 years; BMI 28.6±7.4 kg/m²) who completed MSLTs were included. 95 participants (22%) had a positive MSLT of ≤ 8 minutes, of which 87% (n=83) had a prior night total sleep time on polysomnography of > 6 hours. Gender, age, and BMI did not vary significantly between participants with a mean sleep latency (MSL) ≤ 8 versus >8 minutes (p=0.9, p>0.9, p=0.1 0, respectively). Participants with an MSL ≤ 8 minutes had higher Epworth Sleepiness Scale scores 14.6 ± 5.1 vs 12.5 ± 5.0 (p < 0.001), with more sleep onset REM periods (SOMREPs) 0.82 ± 1.35 vs 0.14 ± 0.49 compared to those with MSL >8 minutes. Further data collection is in progress, but to date, diagnoses were available for 34 participants with MSL ≤ 8 minutes (6 NT1, 8 NT2, 8 IH, 12 Other [i.e., shiftwork disorder, sleep restriction, medication-induced]). Discussion This study seeks to estimate diagnostic frequency and characteristics of patients presenting for evaluation of hypersomnolence. The prevalence of MSL < 8 minutes (22.0%) is consistent with prior studies1,2. Analysis of diagnostic outcomes is pending further data collection in progress.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在南澳大利亚调查嗜睡障碍:多次睡眠潜伏期测试的回顾性审计
摘要:本研究旨在评估1型嗜睡症(NT1)、2型嗜睡症(NT2)和特发性嗜睡症(IH)患者的特征,以及在澳大利亚一家医院进行多次睡眠潜伏期试验(MSLT)的患者的诊断结果。方法对2018年1月至2023年1月期间完成MSLT的所有患者进行回顾性审计。结果431人,其中女性62.4%;平均±SD年龄40.2±16.4岁;BMI(28.6±7.4 kg/m²)完成MSLTs的患者纳入。95名参与者(22%)的MSLT阳性≤8分钟,其中87% (n=83)的多导睡眠图显示,他们之前的总睡眠时间为>6小时。性别、年龄和BMI在平均睡眠潜伏期(MSL)≤8和>8分钟的参与者之间没有显著差异(p=0.9, >0.9, p=0.1)。睡眠时间≤8分钟的受试者Epworth嗜睡量表得分更高(14.6±5.1 vs 12.5±5.0)。0.001),与睡眠时间为8分钟的患者相比,睡眠开始期(somrep)(0.82±1.35 vs 0.14±0.49)更长。进一步的数据收集正在进行中,但迄今为止,34名MSL≤8分钟的参与者(6名NT1, 8名NT2, 8名IH, 12名其他[即轮班障碍,睡眠限制,药物引起的])可诊断。本研究旨在评估嗜睡患者的诊断频率和特征。MSL的患病率<8分钟(22.0%)与先前研究一致1,2。诊断结果的分析有待进一步的数据收集。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Central Role of Sulcal Width in the Associations of Sleep Duration and Depression with Cognition in Mid to Late Life Clinical and Financial Significance of Insomnia within a Large Payor-Provider Health System Impact of Real-World Implementation of Evidence-Based Insomnia Treatment within a Large Payor-Provider Health System: Initial Provider and Patient-Level Outcomes Poor Sleep and Inflammatory Gene Expression Among Care Partners of Persons Living with Dementia: A Pilot Trial of a Behavioral Sleep Intervention Sex-Specific Associations Between Habitual Snoring and Cancer Prevalence: Insights from a U.S. Cohort Study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1